Bidirectional associations in comorbid diseases
https://doi.org/10.30629/0023-2149-2021-99-3-234-236
Abstract
The increasing number of patients with comorbid diseases with polypharmacotherapy requires the search for optimal approaches to the treatment. The article discusses clinical aspects of bilateral connection manifested by an increase in frequency, severity and worsening prognosis of comorbid diseases. Common risk factors and pathophysiological mechanisms of diseases can serve as a basis for the development of optimal treatment of patients with comorbidity.
About the Author
F. I. BelyalovRussian Federation
Farid I. Belyalov - MD, PhD, DSc, professor of the Gerontology, Geriatry, and Clinical Pharmacology Department
Irkutsk, 664079
References
1. Co nrad N., Judge A., Tran J. et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018;391(10120):572–580. DOI: 10.1016/S0140-6736(17)32520-5
2. Bu ttorff C., Ruder T., Bauman M. Multiple chronic conditions in the United States. Santa Monica (CA): RAND Corporation. 2017.
3. Brugts J.J., Linssen G.C.M., Hoes A.W. et al. Re al-world heart failure management in 10, 910 patients with ch ronic heart failure in the Netherlands : Design and rationale of the Chronic Heart failure ESC guideline-based Cardiology practice Quality project (CHECK-HF) registry. Neth Heart J. 2018;26(5):272–279. DOI: 10.1007/s12471-018-1103-7
4. Williams J.S., Egede L.E. Th e Association Between Multimorbidity and Quality of Life, Health Status and Functional Disability. Am. J. Med. Sci. 2016;352(1):45–52. DOI: 10.1016/j.amjms.2016.03.004
5. Park S, Rim S, Kim C, et al. Eff ect of comorbid depression on health-related quality of life of patients with chronic diseases: A South Korean nationwide study (2007–2015). Journal of Psychosomatic Research. 2019;116:17–21. doi: 10.1016/j.jpsychores.2018.11.004
6. Белялов Ф.И. Лечение болезней в условиях коморбидности. 11-е изд. Москва: ГЭОТАР-Медиа, 2019:512.
7. Wi um-Andersen M., Wium-Andersen I., Prescott E. et al. An attempt to explain the bidirectional association between ischaemic heart disease, stroke and depression: a cohort and meta-analytic approach. The British Journal of Psychiatry. 2020;217:434–441. DOI: 10.1192/bjp.2019.130
8. Kim S.Y., Kim H.J., Lim H. et al. Bidirectional association be tween gastroesophageal refl ux disease and depression: Two diff erent nested case-control studies using a national sample cohort. Sci. Rep. 2018;8(1):11748. DOI: 10.1038/s41598-018-29629-7
9. Белялов Ф.И. Психосоматика. 8-е изд. Москва: ГЭОТАР-Медиа, 2019:360.
10. Pr eiss D., Zetterstrand S., McMurray J.J.V. et al. Predictors of Development of Di abetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Diabetes Care. 2009;32(5):915–20. DOI: 10.2337/dc08-1709
11. Preiss D., van Veldhuisen D.J., Sattar N. et al., Eplerenone and new-onset diabetesin pa tients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). Eur. J. Heart Fail. 2012;14:909–915. DOI: 10.1093/eurjhf/hfs067
12. Du nlay S.M., Givertz M.M., Aguilar D. et al. Ty pe 2 Diabetes Mellitus and Heart Failure: A Scientifi c Statement From the American Heart Association and the Heart Failure Society of America. Circulation. 2019;140(7):e294–e324. DOI: 10.1161/CIR.0000000000000691
13. Se ferović P., Petrie M., Filippatos G. et al. Ty pe 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 2018;5:853–872. DOI: 10.1002/ejhf.1170
14. Bobo W., Ryu E., Petterson T. et al. Bi -directional association between depression and HF: An electronic health records-based cohort study. J. Comorb. 2020;10:2235042X20984059. DOI: 10.1177/2235042X20984059
15. Chen P.C., Chan Y.T., Chen H.F. et al. Population-Based Cohort Analyses of the Bi directional Relationship Between Type 2 Diabetes and Depression. Diabetes Care. 2013;36(2):376–82. DOI: 10.2337/dc12-0473
16. Odutayo A., Wong C.X., Hsiao A.J. et al. Atrial fi brillation and risks of ca rdiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016;354. DOI: 10.1136/bmj.i4482
17. Bansal N. еt al. eGFR and Albuminuria in Relation to Risk of Incident Atrial Fi brillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study. CJASN. 2017;12(9):1386–1398. DOI: 10.2215/CJN.01860217
18. Pan A., Teng G.G., Yuan J.M. et al. Bi directional Association between Self-Reported Hypertension and Gout: The Singapore Chinese Health Study. PLoS One. 2015;10(10):e0141749. DOI: 10.1371/journal.pone.0141749
19. Standl E., Stevens S., Lokhnygina Y. et al. Confi rming the Bidirectional Nature of the As sociation Between Severe Hypoglycemic and Cardiovascular Events in Type 2 Diabetes: Insights From EXSCEL. Diabetes Care. 2020;3:643–652. doi: 10.2337/dc19-1079
20. Wu Y., Murray G., Byrne E., et al. GW AS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression. Nature Communications. 2021;1:1146. doi: 10.1038/s41467-021-21280-7
21. Dumbreck S., Flynn A., Nairn M. et al. Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ. 2015;350:h949
Review
For citations:
Belyalov F.I. Bidirectional associations in comorbid diseases. Clinical Medicine (Russian Journal). 2021;99(3):234-236. (In Russ.) https://doi.org/10.30629/0023-2149-2021-99-3-234-236